Ckd career

  1. Stages of Chronic Kidney Disease (CKD Stages)
  2. Adults with chronic kidney disease: Overview and nursing care goals
  3. Keeping Your Job When You Have Chronic Kidney Disease
  4. Employment
  5. Chronic Kidney Disease: Evaluation and Treatment Guidelines from the VA/DoD


Download: Ckd career
Size: 39.20 MB

Stages of Chronic Kidney Disease (CKD Stages)

eGFR 90 or higher What it means: • Kidney damage with normal kidney function Possible signs and symptoms: • High blood pressure, swelling in legs, urinary tract infections, abnormal urine test What you can do: • See your doctor regularly to monitor your health, • Make healthy lifestyle choices: eat well, quit • Take all medications as directed and ask your doctor before taking any over-the-counter medications. eGFR 60–89 What it means: • Mild loss of kidney function Possible signs and symptoms: • High blood pressure, swelling in legs, urinary tract infections, abnormal urine test What you can do: • See your doctor regularly to monitor your health, • Make healthy lifestyle choices: eat well, quit • Take all medications as directed and ask your doctor before taking any over-the-counter medications. eGFR 45-59 What it means: • Mild to moderate loss of kidney function Possible signs and symptoms: • Changes in urination, swelling in hands and feet, weakness or fatigue, dry and itchy skin, back pain, muscle cramping What you can do: • See your doctor to discuss any changes in your lab values or symptoms you may be experiencing. • Meet with a renal dietitian to address any nutrition concerns and to learn about eating well. Explore some eGFR 30-44 What it means: • Moderate to severe loss of kidney function Possible signs and symptoms: • Changes in urination, swelling in hands and feet, weakness or fatigue, dry and itchy skin, back pain, muscle cramping What you can do: • See your ...

Adults with chronic kidney disease: Overview and nursing care goals

• Journal • Current Journal • Archives • Reader Feedback • Author Guidelines • Send a Letter to the Editor • Peer Review Guidelines • Editorial Board • Publication Ethics • Subscribe • CNE • Clinical Topics • Cardio-Pulmonary • Critical Care • Depression • Drugs and Devices • Healthcare & Technology • Immune/Lymphatic System • Infection Control • Infectious Diseases • Infection Prevention • Leading the Way • Legal & Ethics • Mental Health • Mind-Body-Spirit • Neurology • Nursing Education • Nursing Leadership • Oncology • Pediatrics • Professional Development • Public Health • Self-Care • Women’s Health • Wellness • Workplace Management • Wound Care • All Topics • Resources • Trends and Salary Interactive Results • Beyond the Pandemic • Educational Webinars • Education and Career Guide • Intelligent Hospital Operations • Podcasts • Research 101 • Dissemination 101 • Nurse Retention Tool Kit • Workplace Violence Resource Center • Advisor Series • Skin Integrity Video Series • 2022 COVID Resource Center • Oncology Resource Center • Patient Centered Staffing • Wound Care Advisor • 02 IQ: Pulse Oximetry in Neonatal Care • Technology Advisor • Nurse Leadership Advisor • Infection Control • Infection Prevention • Opioid Advisor • Nurse Mental Health • Urgent Care Advisor • Community • American Nurse Heroes • All-Pro Nursing Award • My Nurse Influencers • Letters to the Editor • Off the Charts • The Writing Mind • Perspectives • News • Magnet® & Pathway® • • Home • Journal • Curr...

Careers

Our team is passionate about making a difference in the lives of 37 million Americans living with kidney disease. We're on a mission to ensure that everyone has access to the lifesaving care they need — and that no one has to fight this isolating disease alone. If you're looking for a career that offers you a sense of purpose, dynamic culture and advancement opportunities, apply to the American Kidney Fund today. As a kidney transplant recipient and employee of AKF, I have seen firsthand the impact that AKF makes every day in the lives of kidney patients and their families. I am extremely thankful to work for an organization that supports kidney patients and advances programs from prevention through transplantation. Shayla H.

Keeping Your Job When You Have Chronic Kidney Disease

A job can be fulfilling, help support a household, provide medical insurance and other benefits, and be socially rewarding. So how do you keep your job when you learn that you have Knowing what you can do at your job when you have kidney disease Whether you work in an office, a factory, a retail store, a warehouse or outdoors, realizing what you can and cannot do at your job is the first step to continue working. People with kidney disease may experience tiredness or weakness, and may consider the type of job they are performing. You may want to talk to your manager or supervisor about what you can do. Is there anything that needs to be modified for your position? Are there different departments that may be more accommodating to your physical needs? Should you work fewer hours or maybe work on different days? For people on dialysis, they will have an You will also have to make time to see your doctor and schedule dialysis treatments. If it is an option perhaps you can work from home some days. Temporary leave when you begin dialysis According to the U.S. Department of Labor, the Family and Medical Leave Act (FMLA) is for covered employers to grant eligible employees 12 weeks of unpaid time off within a 12-month period for certain reasons. People with chronic kidney disease may be able to take advantage of FMLA to get time off and keep their job. FMLA will help when you get an access operation or train for You can also consider using paid time off or vacation time if you ne...

Employment

• You need a plan of action when you want to stay employed after a kidney disease diagnosis. Use this checklist to help with your transition. • Find the right treatment options for your lifestyle. • Browse 1,200+ kidney-friendly recipes to better manage your diet. • Access and track your lab results. • Follow these steps for talking with your employer about your kidney disease. • If you have questions regarding working and insurance and are not yet on dialysis, a patient advocate is here to help • Understand your rights under the ADA. • Learn why working may keep you healthier and happier. • Discover how Cecilia overcame the news that she needed dialysis and how the treatment she chose helped her continue working. • As a dancer and instructor, it was imperative that a kidney disease diagnosis didn't keep Chris down. See how Chris got back to doing what she loves.

Chronic Kidney Disease: Evaluation and Treatment Guidelines from the VA/DoD

Screening for CKD does not improve outcomes in any population, and the VA/DoD recommend screening based on clinical risk and shared decision-making. CKD is staged based on estimated glomerular filtration rate (eGFR) as shown in 2. Doing so may reduce the misclassification of CKD in up to 40% of patients and may result in a higher classification stage for 25% of those with CKD. One meta-analysis suggests reduced mortality in CKD when systolic blood pressure is maintained below 140 mm Hg. Angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) should be used to treat patients who have CKD with albuminuria and diabetes mellitus. For CKD with albuminuria but no diabetes, an ACE inhibitor is preferred because of a 31% reduction in end-stage renal disease. Both medications cause increases in potassium and creatinine levels in CKD, so monitoring is essential; combinations of ACE inhibitors and ARBs should not be used. ARBs are an appropriate alternative for ACE inhibitor–induced cough, but they are not appropriate after angioedema. No other antihypertensive medications reduce CKD progression. Consider additional treatment with sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists to reduce CKD progression. SGLT-2 inhibitors slow CKD progression and reduce hospitalization for heart failure, with uncertain effect on mortality. Based on a post-hoc trial analysis, GLP-1 receptor agonists appear to re...